Literature DB >> 884909

Dialysis in the treatment of renal failure in patients with liver disease.

S P Wilkinson, M J Weston, V Parsons, R Williams.   

Abstract

The value and effects of treating renal failure by dialysis are analyzed in a series of 84 patients with various types of liver disease. Although none of the 25 patients with cirrhosis survived, six of 50 with fulminant hepatic failure recovered completely as did seven of nine patients with renal failure secondary to extrahepatic biliary tract obstruction or with liver and renal damage following episodes of severe hypotension. Dialysis was required for seven weeks before diuresis occurred in one patient in the latter group. Both peritoneal and hemodialysis satisfactorily controlled plasma urea and creatinine levels, except in patients with fulminant hepatic failure in whom this was only achieved by hemodialysis. Complications of dialysis were most common in patients with cirrhosis and fulminant hepatic failure and included hypotension, gastrointestinal bleeding, and intraperitoneal sepsis. Overall, the results show that dialysis is only worth attempting in those patients in whom recovery of the underlying liver lesion is possible, and even then treatment for prolonged periods may be necessary.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 884909

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  20 in total

Review 1.  Hepatorenal syndrome: Update on diagnosis and treatment.

Authors:  Olga Baraldi; Chiara Valentini; Gabriele Donati; Giorgia Comai; Vania Cuna; Irene Capelli; Maria Laura Angelini; Maria Ilaria Moretti; Andrea Angeletti; Fabio Piscaglia; Gaetano La Manna
Journal:  World J Nephrol       Date:  2015-11-06

2.  The hepatorenal syndrome revisited.

Authors:  S P Wilkinson
Journal:  Intensive Care Med       Date:  1987       Impact factor: 17.440

3.  The hepatorenal syndrome.

Authors:  M Pinzani; R D Zipser
Journal:  Intensive Care Med       Date:  1987       Impact factor: 17.440

4.  Treatment of ascites in patients with cirrhosis of the liver.

Authors:  V Arroyo; P Ginés; J Rodés
Journal:  Intensive Care Med       Date:  1987       Impact factor: 17.440

5.  Prognosis of Patients with Cirrhosis and AKI Who Initiate RRT.

Authors:  Andrew S Allegretti; Xavier Vela Parada; Nwamaka D Eneanya; Hannah Gilligan; Dihua Xu; Sophia Zhao; Jules L Dienstag; Raymond T Chung; Ravi I Thadhani
Journal:  Clin J Am Soc Nephrol       Date:  2017-11-09       Impact factor: 8.237

6.  Therapeutic alternatives for the treatment of type 1 hepatorenal syndrome: A Delphi technique-based consensus.

Authors:  Juan P Arab; Juan C Claro; Juan P Arancibia; Jorge Contreras; Fernando Gómez; Cristian Muñoz; Leyla Nazal; Eric Roessler; Rodrigo Wolff; Marco Arrese; Carlos Benítez
Journal:  World J Hepatol       Date:  2016-09-08

7.  Efficiency of respiratory assistance in cirrhotic patients with liver failure.

Authors:  G Goldfarb; O Nouel; T Poynard; B Rueff
Journal:  Intensive Care Med       Date:  1983       Impact factor: 17.440

8.  The reversal of the hepatorenal syndrome in four pediatric patients following successful orthotopic liver transplantation.

Authors:  R P Wood; D Ellis; T E Starzl
Journal:  Ann Surg       Date:  1987-04       Impact factor: 12.969

9.  Renal failure in fulminant hepatic failure and terminal cirrhosis: a comparison between incidence, types, and prognosis.

Authors:  H Ring-Larsen; U Palazzo
Journal:  Gut       Date:  1981-07       Impact factor: 23.059

10.  Evaluation of urine as a clinical specimen for diagnosis of hepatitis a.

Authors:  Madhuri S Joshi; Shobha D Chitambar; Vidya A Arankalle; Mandeep S Chadha
Journal:  Clin Diagn Lab Immunol       Date:  2002-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.